Top 18 Neurology startups in USA
Oct 31, 2025
Like
27
1
Funding: $614.6M
Neumora Therapeutics is pioneering a new era of precision medicines for Brain Diseases
Neumora Therapeutics is pioneering a new era of precision medicines for Brain Diseases
2
Funding: $457.1M
NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
3
Funding: $366.2M
Alzheon is committed to developing innovative medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. Our Alzheon’s drug development platform which comprises proprietary chemistries, robust clinical efficacy and safety datasets in patients and genetically-defined subpopulations, and the ability to optimize molecules to have the desired therapeutic attributes.
Alzheon is committed to developing innovative medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. Our Alzheon’s drug development platform which comprises proprietary chemistries, robust clinical efficacy and safety datasets in patients and genetically-defined subpopulations, and the ability to optimize molecules to have the desired therapeutic attributes.
4
Funding: $319.5M
Alector is a hypothesis-driven, neurology-focused startup that’s pioneering the discovery and development of first-in-class, immuno-modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. We are combining state-of-the-art antibody technology and recent discoveries in neuro-immunology and human genetics to develop a broad platform of novel therapeutics that harness the immune system to fight dementia and neurodegeneration.
Alector is a hypothesis-driven, neurology-focused startup that’s pioneering the discovery and development of first-in-class, immuno-modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. We are combining state-of-the-art antibody technology and recent discoveries in neuro-immunology and human genetics to develop a broad platform of novel therapeutics that harness the immune system to fight dementia and neurodegeneration.
5
Funding: $260M
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
6
Funding: $220.5M
Ceribell is focused on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective
Ceribell is focused on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective
7
Funding: $181.2M
Skyhawk's is developing small molecule therapeutics that correct RNA expression.Their proprietary technology enables the rational design of small molecules that target the RNA splicing process.They are now developing drug candidates for cancer, neurological disease, and rare disease.
Skyhawk's is developing small molecule therapeutics that correct RNA expression.Their proprietary technology enables the rational design of small molecules that target the RNA splicing process.They are now developing drug candidates for cancer, neurological disease, and rare disease.
8
Funding: $180.1M
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.
9
Funding: $134.9M
NeuSpera develops implantable medical devices for treating chronic illnesses through minimally invasive solutions.
NeuSpera develops implantable medical devices for treating chronic illnesses through minimally invasive solutions.
10
Funding: $109M
Nido Biosciences develops new precision medicines for neurological diseases and takes aim at Kennedy’s disease, a rare degenerative disorder.
Nido Biosciences develops new precision medicines for neurological diseases and takes aim at Kennedy’s disease, a rare degenerative disorder.
11
Funding: $86.9M
Vaccinex is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.
Vaccinex is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.
12
Funding: $78.2M
We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US
We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US
13
Funding: $73.7M
Neural Analytics is addressing the global traumatic brain injury epidemic through data science. The company develops robotically assisted ultrasound system for brain health assessment. The company’s technology integrates ultrasound, robotics and machine learning to empower neurologists with critical information about brain health
Neural Analytics is addressing the global traumatic brain injury epidemic through data science. The company develops robotically assisted ultrasound system for brain health assessment. The company’s technology integrates ultrasound, robotics and machine learning to empower neurologists with critical information about brain health
14
Funding: $52.5M
Rune Labs is a software and data platform for neuromodulation and brain therapies of the future.
Rune Labs is a software and data platform for neuromodulation and brain therapies of the future.
15
Funding: $14.4M
AgeneBio is developing innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function.
AgeneBio is developing innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function.
16
Funding: $14.2M
Sense Neuro Diagnostics is a developer of non-invasive medical devices for neurological conditions.
Sense Neuro Diagnostics is a developer of non-invasive medical devices for neurological conditions.
17
Funding: $2.6M
dannce.ai uses AI-driven 3D-aligned neural networks to automate behavioral analysis for faster, more accurate drug development and clinical care.
dannce.ai uses AI-driven 3D-aligned neural networks to automate behavioral analysis for faster, more accurate drug development and clinical care.
18
VistaraBio is applying their proteostasis technologies for target identification in Parkinson's and other neurodegenerative diseases.
★
See also:
